Harrow Health Inc (HROW) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $53.99
• Market Cap: $1.98B
• EPS: $-0.13
• 52-Week High: $54.85
• 52-Week Low: $20.85

Market Sentiment

Harrow Health Inc currently has a Bullish sentiment score of 0.31.

About Harrow Health Inc

Harrow Health, Inc. is a leading healthcare company headquartered in San Diego, California, specializing in the development and commercialization of innovative ophthalmic products. With a strong focus on proprietary formulations and drug delivery technology, Harrow Health is dedicated to enhancing patient outcomes across a spectrum of ocular conditions and surgical requirements. The company boasts a robust portfolio of FDA-approved products, positioning it to effectively leverage the increasi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Harrow Health Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HROW pay dividends?

Harrow Health Inc (HROW) does not currently pay a regular dividend.

What is HROW's market cap?

Harrow Health Inc (HROW) has a market capitalization of $1.98B with a current stock price of $53.99.